Manipulating the Microbiome to Manage Disease

Cammie Lesser will discuss how she turns a probiotic into a drug-delivering machine, while Andrew Y. Koh will describe the connection between the gut microbiota and cancer immunotherapy efficacy.

Event Details:Manipulating the Microbiome to Manage DiseaseDate(s):

FREE Webinar

Monday, June 21, 2021
2:30 - 4:00 PM, Eastern Time

Register Now

The human microbiome is an intricate system, and its role in health and disease is currently under intense investigation. Altering the microbiome with beneficial organisms and editing the species that are already established holds promise for treating a variety of diseases. In this webinar brought to you by The Scientist and Tecan, Cammie Lesser and Andrew Koh will discuss how they plan to manage disease by manipulating the microbiome.

Topics to be covered

Register Now

Meet the Speakers:

Cammie Lesser, MD, PhD
Associate Professor, Medicine (Microbiology)
Harvard Medical School
Associate Director Center for Bacterial Pathogenesis
Massachusetts General Hospital

Andrew Y. Koh, MD
Associate Professor, Pediatrics and Microbiology
UT Southwestern Medical Center
Director, Cellular and ImmunoTherapeutics Program
Children's Health

Sponsored by

genomics.png

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies